Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$50.07 - $66.05 $897,855 - $1.18 Million
-17,932 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$56.61 - $80.46 $39,796 - $56,563
-703 Reduced 3.77%
17,932 $1.13 Million
Q1 2021

May 17, 2021

BUY
$86.23 - $125.19 $639,826 - $928,909
7,420 Added 66.16%
18,635 $1.73 Million
Q4 2020

Feb 16, 2021

BUY
$79.17 - $111.47 $887,891 - $1.25 Million
11,215 New
11,215 $1.01 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track American Capital Management Inc Portfolio

Follow American Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Management Inc with notifications on news.